BioEurope Spring Conference (Noxxon) - Mar 15, 2011 - Spiegelmer (NOX-E36) / Noxxon; Initiation of P2a trial in diabetic nephropathy Q4'11; Anticipated P1b study completion in diabetics; Anticipated renal impairment study completion in Q3 '11
Anticipated P1b study completion • Anticipated P2 enrollment • Renal Disease
|